Philadelphia-based Penn Medicine obtained Independence Blue Cross clinical care innovation grants for three projects that aim to improve patient health and wellbeing.
The first project provides remote supervised rehabilitation for patients who suffered from acute heart-disease-related conditions.
Also awarded a grant was Penn Medicine's LiveAware, which aids in cancer screening by both reducing clinician need to determine eligibility and promoting "on-time image-based screening."
The final grant supported a text messaging system that helps at-home oral chemotherapy patients apply treatment. In addition to limiting visits for patients, the system aims to increase treatment schedule consistency and manage side effects.
The grant money, which averages $200,000 per grant, will be used to further develop the projects through trials to expand their use.